背带缝合联合欣母沛治疗产后出血的临床效果
2024-01-21刘文敏杜晓虹刘霞
刘文敏 杜晓虹 刘霞


【摘要】目的:分析背带缝合联合欣母沛治疗产后出血的临床效果。方法:选取我院2022年1月—2023年1月的120例产后出血患者,随机将其分成为两组。对照组采取缩宫素,观察组采取背带缝合联合欣母沛。结果:观察组的产后2 h出血量、止血成功时间和產后24h出血量明显更低(P<0.05);治疗前,两组的FIB、凝血因子Ⅶ、APTT、PLT计数和PT水平不具有明显的差别(P>0.05),治疗后,两组以上指标均改善(P<0.05),且观察相较于对照组来说,更优(P<0.05);治疗前,两组应激反应指标水平无差异(P>0.05),治疗后,两组的应激反应指标水平均降低(P<0.05),且观察相较于对照组来说,更低(P<0.05)。结论:背带缝合联合欣母沛对产后出血有较好的效果。
【关键词】背带缝合;欣母沛;产后出血
Clinical effect of dorsal suture combined with Hemabate in the treatment of postpartum hemorrhage
LIU Wenmin, DU Xiaohong, LIU Xia
Hospital of Traditional Chinese Medicine, Wudu District, Longnan, Gansu 741000, China
【Abstract】Objective: To analyze the clinical effect of dorsal suture combined with Hemopax in the treatment of postpartum hemorrhage. Methods: 120 patients with postpartum hemorrhage in our hospital from January 2022 to January 2023 were selected and randomly divided into two groups. The control group was treated with oxytocin, and the observation group was treated with dorsal suture combined with Hemabate. Results: The amount of postpartum bleeding at 2 hours, the time to hemostasis success and the amount of bleeding at 24 hours after delivery were significantly lower in the observation group (P<0.05). Before treatment, there was no significant difference in FIB, coagulation factor VII, APTT, PLT count, and PT levels between the two groups (P>0.05). After treatment, more than two groups indicators improved (P<0.05), and the observation was better than the control group (P<0.05). Before treatment, there was no difference in the levels of stress response indicators between the two groups (P>0.05). After treatment, the levels of stress response indicators in both groups decreased (P<0.05), and compared to the control group, they were observed to be lower (P<0.05). Conclusion: Dorsal suture combined with Hemabate has a better effect on postpartum hemorrhage.
【Key Words】Dorsal suture; Hemabate; Postpartum hemorrhage
产后出血在临床上比较常见,临床必须给予患者及时有效的治疗[1]。该病的治疗原则是控制出血量并马上止血。因此,临床治疗中常常采取宫缩药物素,因此必须寻求安全且有效的药物以缩短出血时间以及控制出血量,从而确保产妇的生命安全。本研究选取产后出血患者120例,在我院治疗时间为2022年1月—2023年1月,随机分成两个小组,分析背带缝合联合欣母沛治疗产后出血的临床 效果。
1 资料与方法
1.1 一般资料
选取产后出血患者120例,在我院治疗时间为2022年1月—2023年1月,随机分成两个小组,各60例。观察组,年龄20~41岁,平均年龄(28.93±2.14)岁,孕周35~41周,平均孕周(38.67±1.42)周;对照组,年龄20~41岁,平均年龄(28.76±1.38)岁,孕周35~41周,平均孕周(38.45±1.29)周。两组资料没有明显的差别(P>0.05)。
1.2 研究方法
对照组:待胎儿娩出后,缩宫素注射液静脉滴注,剂量为20 U,滴速80 mU/min。观察组:待胎儿娩出后,联合欣母沛250μg的欣母沛静脉注射,采取可吸收线在患者子宫切口右侧下缘部位穿入子宫,将线拉至子宫底部位,从右往左,从外往内,斜方向进针,且穿透产后出血患者的子宫浆膜层、蜕膜层和肌层,于左侧子宫底韧带上方部位出针,然后对左侧实施同样的操作;于……
